★ Sign in to follow
PA

Pharmiva AB (publ) Stock: price and insider trades · Sweden

ISIN SE0015658885SE·

No insider purchase over the last 90 days. The latest, by Anna Linton, was filed 03 Jan 2023.

Pharmiva AB (publ): what insiders have been doing

Pharmiva AB (publ) is a listed company. Its insiders report their share dealings to Finansinspektionen. No insider at Pharmiva AB (publ) has published a filing in the past twelve months. The most recent one dates from 3 January 2023.

Over the whole record (from 2021), the tally stands at 11 purchases and no sales.

Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€25,854
11 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 3 January 2023
Declarations16 total
  • ▲
    Anna Linton
    Verkställande direktör (VD)Executives
    7,665 SEK23FI-SE
    4,646 shares@ SEK 1.64987.7% of flowAktieISIN SE0015530670FI:csv-23862713d09f304da42c
    Canonical exit: 2 Apr 2023 (T+90)
  • ▲
    Anna Linton
    Verkställande direktör (VD)Executives
    29,750 SEK25FI-SE
    17,500 shares@ SEK 1.7029.8% of flowAktieISIN SE0015530670FI:csv-69d6ee41f065afca821c
    Canonical exit: 3 Apr 2023 (T+90)
  • ▲
    Anna Linton
    Verkställande direktör (VD)Executives
    31,251 SEK25FI-SE
    18,940 shares@ SEK 1.6531.7% of flowAktieISIN SE0015530670FI:csv-cba27c3069e100b8c2bf
    Canonical exit: 20 Mar 2023 (T+90)
  • ●
    Anna Linton
    Verkställande direktör (VD)Executives
    29,999 SEK0FI-SE
    16,666 shares@ SEK 1.8030.8% of flowBTA (betald tecknad aktie)ISIN SE0018536922FI:csv-1fff1e526d56412dd064
  • ●
    Malte Zaunders
    StyrelseordförandeExecutives
    476,280 SEK0FI-SE
    264,600 shares@ SEK 1.8066.6% of flowBTA (betald tecknad aktie)ISIN SE0018536922FI:csv-0827b89525724bc49dca
  • ●
    Malte Zaunders
    StyrelseordförandeExecutives
    23,717 SEK0FI-SE
    13,176 shares@ SEK 1.803.3% of flowBTA (betald tecknad aktie)ISIN SE0018536922FI:csv-7d303c3b91cae7361377
  • ●
    David Sagna
    StyrelseledamotExecutives
    149,998 SEK0FI-SE
    83,332 shares@ SEK 1.80100.0% of flowBTA (betald tecknad aktie)ISIN SE0015530670FI:csv-8dd3e6e374642c6724b6
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    8,820 SEK0FI-SE
    6,000 shares@ SEK 1.471.3% of flowTeckningsoptionISIN SE0015658885FI:csv-204d4be31c6d347c7ed0
    Canonical exit: 1 Jun 2022 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    19,995 SEK7FI-SE
    2,072 shares@ SEK 9.653.0% of flowAktieISIN SE0015530670FI:csv-d2540f27d2b052b98a1c
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    17,726 SEK7FI-SE
    1,818 shares@ SEK 9.752.7% of flowAktieISIN SE0015530670FI:csv-879a0bf1156c64033d68
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    4,975 SEK7FI-SE
    500 shares@ SEK 9.950.8% of flowAktieISIN SE0015530670FI:csv-c28e1ba142232fec2683
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    1,795 SEK7FI-SE
    191 shares@ SEK 9.400.3% of flowAktieISIN SE0015530670FI:csv-bcc831ae84a604aea60c
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    29,937 SEK7FI-SE
    3,061 shares@ SEK 9.784.5% of flowAktieISIN SE0015530670FI:csv-c90d493f7f80afd2d667
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    25,922 SEK7FI-SE
    2,600 shares@ SEK 9.973.9% of flowAktieISIN SE0015530670FI:csv-a5f96cc030b3ac855d11
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Malte Zaunders
    StyrelseordförandeExecutives
    90,469 SEK8FI-SE
    9,523 shares@ SEK 9.5013.7% of flowAktieISIN SE0015530670FI:csv-ef566fe8d797efc9306d
    Canonical exit: 23 Aug 2021 (T+90)
  • ●
    Ulf Blom
    StyrelseledamotExecutives
    0FI-SE
    1,563 shares0TeckningsoptionISIN SE0015658885FI:A001R762-2

16 of 16 declarations

About Pharmiva AB (publ)

Pharmiva AB (publ) is a publicly traded company on the Stockholm Stock Exchange, specializing in the development of pharmaceutical products. It focuses on innovative solutions for patient health and well-being.

Related companies and executives

No related entities found.